NEW YORK (GenomeWeb News) – Cellumen said today that it will provide analysis services for the second phase of the US Environmental Protection Agency's ToxCast program.
Cellumen said that the work with EPA "could generate" up to $5.5 million for the company, but did not disclose further financial details.
The company has been participating in the ToxCast program since 2007. In the first proof-of-concept phase, Cellumen generated hepatic toxicity data using its CellCiphr platform. Under the expanded agreement, the company will generate CellCiphr profiles for "thousands" of chemicals.
ToxCast is an EPA initiative that aims to reduce the time and costs associated with toxicity testing of chemicals.